Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Interaction Study of LC350189 and Naproxen in Healthy Subjects
NCT04139824Phase 1Completed
- Sponsor
- LG Chem
- Start
- Jan 2020
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of tigulixostat in gout and hyperuricemia, sponsored by LG Chem. Primary endpoints: Maximum Observed Concentration at Day 18, Area Under the Concentration-Time Curve at Day 18 and 1 more. Started Jan 2020; status: completed.
02
Drugs
tigulixostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on NCT04139824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04139824.